Stock Research: Inspire Medical Systems

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Inspire Medical Systems

NYSE:INSP US4577301090
36
  • Value
    100
  • Growth
    31
  • Safety
    Safety
    32
  • Combined
    69
  • Sentiment
    16
  • 360° View
    360° View
    36
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Inspire Medical Systems, Inc. is a medical technology company developing minimally invasive solutions for obstructive sleep apnea (OSA). It operates in the medical technology industry with its proprietary Inspire therapy. The company sells its Inspire system in the United States, Europe, Japan, Singapore, and Hong Kong. In the last fiscal year, the company had a market cap of $3775 million, profits of $680 million, revenue of $803 million, and 1246 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 36 (better than 36% compared with alternatives), overall professional sentiment and financial characteristics for the stock Inspire Medical Systems are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for Inspire Medical Systems. The only rank that is above average is the consolidated Safety Rank at 100, which means that the company has a financing structure that is safer than those of 100% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 32, which means that the share price of Inspire Medical Systems is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 31, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 16, which means that professional investors are more pessimistic about the stock than for 84% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 9 19 7
Growth
31 81 81 97
Safety
Safety
100 100 35 4
Sentiment
16 96 37 96
360° View
360° View
36 98 32 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
26 49 49 60
Opinions Change
14 89 43 67
Pro Holdings
n/a 84 1 82
Market Pulse
48 89 78 69
Sentiment
16 96 37 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
32 9 19 7
Growth
31 81 81 97
Safety Safety
100 100 35 4
Combined
69 85 32 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
12 5 20 10
Price vs. Earnings (P/E)
55 22 19 1
Price vs. Book (P/B)
59 32 19 4
Dividend Yield
1 1 1 1
Value
32 9 19 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
70 76 82 83
Profit Growth
10 80 52 52
Capital Growth
73 53 86 73
Stock Returns
15 53 41 75
Growth
31 81 81 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
100 100 100 67
Refinancing
53 33 15 5
Liquidity
98 100 23 23
Safety Safety
100 100 35 4

Similar Stocks

Discover high‑ranked alternatives to Inspire Medical Systems and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.